UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells  by Mao, Weiguang et al.
UCP4, a novel brain-speci¢c mitochondrial protein that reduces
membrane potential in mammalian cells
Weiguang Mao1;a, Xing Xian Yua, Alan Zhongb, Wenlu Lid, Jennifer Brushb,
Steven W. Sherwoodc, Sean H. Adamsa, Guohua Pana;*
aDepartment of Endocrinology, Genentech, Inc., M/S-371, 1 DNA Way, South San Francisco, CA 94080, USA
bDepartment of Molecular Biology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA
cDepartment of Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA
dDepartment of Pharmacokinetics and Metabolism, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA
Received 3 December 1998; received in revised form 10 December 1998
Abstract Uncoupling proteins (UCPs) are a family of mito-
chondrial transporter proteins that have been implicated in
thermoregulatory heat production and maintenance of the basal
metabolic rate. We have identified and partially characterized a
novel member of the human uncoupling protein family, termed
uncoupling protein-4 (UCP4). Protein sequence analyses showed
that UCP4 is most related to UCP3 and possesses features
characteristic of mitochondrial transporter proteins. Unlike
other known UCPs, UCP4 transcripts are exclusively expressed
in both fetal and adult brain tissues. UCP4 maps to human
chromosome 6p11.2^q12. Consistent with its potential role as an
uncoupling protein, UCP4 is localized to the mitochondria and
its ectopic expression in mammalian cells reduces mitochondrial
membrane potential. These findings suggest that UCP4 may be
involved in thermoregulatory heat production and metabolism in
the brain.
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1. Introduction
Food intake and energy expenditure are highly regulated
biological processes that are central to the control of body
weight [1]. Identi¢cation of leptin and its receptors has greatly
facilitated our understanding of these processes [2]. Recently,
much e¡ort has been directed toward understanding the
underlying molecular mechanisms of energy expenditure and
its regulation. A family of mitochondrial proteins, termed
uncoupling proteins (UCPs), have been identi¢ed and impli-
cated as potential modulators of thermoregulation, body com-
position, metabolism, and obesity [3^9].
UCPs are mitochondrial transporter proteins that create
proton leaks across the inner mitochondrial membrane, thus
uncoupling oxidative phosphorylation from ATP synthesis.
As a result, energy is dissipated in the form of heat [3]. Mi-
tochondrial proton leak has been observed in the major oxy-
gen-consuming tissues, including liver, kidney, brain and
muscle, contributing substantially to the standard metabolic
rate [10^12]. The ¢rst characterized uncoupling protein,
UCP1, is normally present only in brown adipocytes, where
it is highly inducible by norepinephrine, thyroid hormones,
retinoic acid, or cold exposure [3]. Mice lacking UCP1 are
cold-intolerant, suggesting that UCP1 is involved in adapta-
tional thermoregulatory heat production [13,14]. Conversely,
UCP2 is widely expressed in human tissues, highest in skeletal
muscle and white adipose tissue and lowest in brain and testis
[4,6]. In situ hybridization analyses revealed UCP2 transcripts
in mouse brain. A high level of expression was detected in the
hypothalamus, but was not a¡ected by cold acclimation [15].
Transcripts of the recently identi¢ed UCP3 are abundant in
rodent skeletal muscle and brown fat [8,9]. Its expression is
regulated by dietary and hormonal manipulations including
thyroid hormone, L3-adrenergic agonists and leptin [7^9,16],
suggesting a role in the regulation of energy expenditure.
Herein, we report the identi¢cation and characterization of
a novel uncoupling protein, termed UCP4. Like other
UCPs, UCP4 was localized to the mitochondria and its ec-
topic expression in mammalian cells led to reduced mito-
chondrial membrane potential. Unlike other known UCPs,
UCP4 transcripts were found to be exclusively present in
the brain.
2. Materials and methods
2.1. Database searches
Both the LIFESEQ database (Incyte Pharmaceuticals, Palo Alto,
CA) and the public EST (expressed sequence tag) database were
searched for novel sequences that had signi¢cant homology to the
known uncoupling proteins. The resultant human EST sequences
were assembled using DNASTAR software (Oxford Molecular
Group, Inc.). Subsequent ‘searching and extending’ cycles led to the
identi¢cation of a cDNA that encoded a full length open reading
frame. A full length cDNA was obtained by polymerase chain reac-
tion (PCR) from a human adult brain cDNA library and con¢rmed
by DNA sequencing.
2.2. Expression constructs
cDNA encoding UCP4 was cloned into pcDNA3 (Invitrogen)
with or without a NH2-terminal Flag tag. DNA primers for
pcDNA3UCP4: 5P-CGCGGATCCCGTTATCGTCTTGCGCTACT-
GC (U401) and 5P-GCGGAATTCTTAAAATGGACTGACTC-
CACTCATC (U406); for pcDNA3Flag-UCP4: 5P-CGCGGATCC-
GAAATGGACTACAAGGACGACGATGACAAGTCCGTCCCG-
GAGGAGGAGG (U410) and U406. cDNA encoding human UCP3
was obtained from a melanoma cDNA library by PCR and subse-
quently cloned into pcDNA3 with or without a NH2 Flag tag and
con¢rmed by DNA sequencing.
2.3. Northern blot analysis
Human multiple tissue Northern blots (Clontech) were probed with
the full length human UCP4 cDNA or UCP2 cDNA according to the
manufacturer’s instructions. The blots were subsequently hybridized
with L-actin cDNA.
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2.4. Subcellular localization
MCF7 cells were transfected with a DNA construct expressing ei-
ther Flag-UCP3 or Flag-UCP4 using FuGENE transfection reagent
(Boehringer Mannheim). The transfected cells were ¢xed in 3% form-
aldehyde at room temperature for 15 min and permeabilized with 1%
Triton X-100 for 15 min. The cells were incubated with both anti-Flag
monoclonal antibody (10 Wg/ml, Kodak) and anti-cytochrome c oxi-
dase polyclonal antibody (3 ng/ml) for 20 min, washed and subse-
quently incubated with Cy3-conjugated and FITC-conjugated (Jack-
son Laboratories) secondary antibodies before examination by
confocal microscopy.
2.5. Analysis of mitochondrial membrane potential by
spectro£uorometry
293T cells were transfected with either pcDNA3 vector alone, or
constructs expressing UCP3 or UCP4 using FuGENE transfection
reagent. Mitochondrial membrane potential was analyzed as previ-
ously described [17,18]. Brie£y, a mitochondrial membrane poten-
tial-sensitive dye, 5,5P,6,6P-tetrachloro-1,1P,3,3P-tetraethylbenzimidazo-
lylcarbocyanine iodide (JC-1, Molecular Probes, Eugene, OR) was
prepared as a stock solution (5 mg/ml) in dimethyl sulfoxide
(DMSO, Sigma). To prepare the staining medium, the stock solution
was diluted to 1 mg/ml with DMSO, and then further diluted to
10 Wg/ml with prewarmed (37‡C) culture medium and ¢ltered through
a 0.2 Wm ¢lter to exclude aggregated JC-1. Transfected cells were
trypsinized and resuspended in culture medium. 1.5U106 cells were
pelleted and resuspended in 0.5 ml of the staining medium and incu-
bated in the presence or absence of 50 WM CCCP (carbonylcyanide
m-chlorophenylhydrazone, Sigma) at 37‡C in the dark for 30 min. The
stained cells were washed, resuspended in 1 ml culture medium, and
examined by spectro£uorometry (RF5000U spectro£uorophotometer,
Shimadzu, Japan). A subset of cells were analyzed by £ow cytometry
(Coulter EPICS Elite ESP, Hialeah, FL). For spectro£uorometric
analysis, excitation was at 488 nm and £uorescence intensity was
measured over the spectrum 500^615 nm. Flow cytometry analysis
was performed with an argon laser of single 488 nm as excitation, a
¢lter transmitting 525 þ 20 nm in FL1 channel, and a ¢lter transmit-
ting above 590 nm in FL2 channel. A minimum of 10,000 cells per
sample were analyzed.
2.6. Statistical analysis
The mean ratios of red (593 nm) versus green (532 nm) £uorescence
intensity peaks from spectro£uorometry were compared across treat-
ments (nine independent transfections per treatment). Di¡erences were
analyzed using Fisher’s protected least signi¢cant di¡erence.
3. Results and discussion
3.1. Identi¢cation and molecular cloning of a new member of
the uncoupling protein family
To identify novel uncoupling proteins, we searched ESTs
using the protein sequence of human UCP3 [16]. Several over-
lapping human EST sequences were initially identi¢ed that
showed signi¢cant homology to the known UCPs. A cDNA
clone containing a full length open reading frame (ORF) was
obtained by PCR as described in Section 2. This ORF en-
coded a protein of 323 amino acids with a predicted molecular
weight of 36 061 Da and a pI of 9.28. Database searches,
protein sequence alignment and comparative analyses revealed
that this molecule was a novel protein and most related to the
established UCPs, possessing 34%, 33% and 29% amino acid
identities to human UCP3, UCP2 and UCP1, respectively.
Interestingly, this molecule was also related to plant uncou-
pling proteins and a putative nematode uncoupling protein
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Fig. 1. Deduced protein sequence of UCP4 and sequence alignments of uncoupling proteins. The open reading frame for UCP4 de¢nes a mito-
chondrial membrane protein of 323 amino acids. The GenBank accession number for the sequence: AF110532. The six putative transmembrane
domains are single underlined and labeled I^VI. The three mitochondrial transporter protein signature motifs are indicated by asterisks. The
putative purine nucleotide binding site is double underlined. Alignment was done with Align software (Genentech, Inc.).
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with 38^46% amino acid identities [19^21]. Based on its pro-
tein sequence and uncoupling activity (see below), this novel
molecule was termed uncoupling protein-4, or UCP4.
Like other UCPs, UCP4 possessed six putative transmem-
brane domains, three mitochondrial transporter protein signa-
ture motifs and a putative nucleotide binding site (Fig. 1). The
uncoupling activity of UCP1 is modulated by nucleotides and
free fatty acids (FFA) [3]. UCP1 lacking its putative nucleo-
tide binding site is resistant to inhibition by nucleotides and
substitution of Phe-267 by Tyr leads to enhanced uncoupling
activity [22^24]. However, like UCP2 and UCP3, UCP4 had a
Tyr residue at this position (Fig. 1). Moreover, the carboxy-
terminus of UCP1 has been implicated in the activation of its
uncoupling activity by FFA. Substitution of Cys-305 by Ala
or Ser results in either decreased or increased activation by
FFA, respectively [25]. Curiously, UCP2 has an Ala (Ala-
307), whereas UCP4 (Ser-321) and UCP3 (Ser-298) have a
Ser at this position, suggesting that the uncoupling activities
of UCPs may be regulated di¡erently by nucleotides and
FFA.
3.2. Tissue distribution of UCP4
The transcripts of the known uncoupling proteins have dis-
tinct tissue distribution patterns [3,6,9]. To examine the ex-
pression pattern of UCP4 transcripts, two human multiple
tissue Northern blots were hybridized with an UCP4 cDNA
probe. Interestingly, UCP4 transcripts (3.3 kb) were only de-
tected in the brain (Fig. 2A). To examine UCP4 transcript
distribution within the brain, two human brain multiple tissue
Northern blots were analyzed. Abundant transcripts were de-
tected in most of the brain tissues, with low levels found in
spinal cord, medulla, corpus callosum and substantia nigra
(Fig. 2B, top). To compare the expression of UCP2 and
UCP4 transcripts in the brain, a human brain multiple tissue
blot was probed with the human UCP2 cDNA. The UCP2
transcripts were detectable in all the brain tissues examined
(Fig. 2B, bottom right). Intriguingly, the highest levels of
UCP2 transcripts were found in the spinal cord and medulla
where the lowest UCP4 transcripts were detected, whereas
much lower levels were observed in the other brain tissues.
To determine whether UCP4 expression was developmen-
tally regulated, a human fetal tissue blot was examined. The
UCP4 transcript was only detected in the fetal brain (Fig. 2B,
bottom left). Taken together, these analyses demonstrate that
UCP4 expression is brain-speci¢c.
Next, we performed radiation-hybrid analysis to determine
chromosome location for UCP4. UCP4 was mapped to hu-
man chromosome 6p11.2^q12 with SHGC-34952 being the
closest genomic marker.
3.3. Subcellular localization of UCP4 in mitochondria
To examine the subcellular location of UCP4, human breast
carcinoma MCF7 cells were transfected with either pcDNA3-
Flag-UCP3 or pcDNA3Flag-UCP4. The cells were stained
with anti-Flag and anti-cytochrome c oxidase (a mitochon-
drial marker). The cell staining patterns for either cytochrome
c oxidase (green image; Fig. 3A,D) or UCP3 or UCP4 (red
image; Fig. 3C,F) showed a typical mitochondrial punctate
staining throughout the cytoplasm with no nuclear or cell
surface staining. As expected, UCP3 or UCP4 was co-local-
ized with cytochrome c oxidase, as indicated by a yellow im-
age for the double staining (Fig. 3B,E), consistent with the
notion that UCP3 and UCP4 are localized in the mitochon-
dria.
3.4. Ectopic expression of UCP4 in mammalian cells resulted in
decreased mitochondrial membrane potential
The biochemical activities of UCPs have been studied in
both mammalian and yeast cells in vitro [3,4,6,16]. Expression
of the known UCPs in these cells leads to a decline in mito-
chondrial membrane potential [3,4,6,8,9,16]. JC-1 is a £uores-
cent dye that has been shown to be a reliable indicator of the
mitochondrial membrane potential changes in intact cells
[17,18,26]. To test whether UCP4 has an uncoupling activity,
we transiently transfected human embryonic kidney 293T with
vector or DNA construct expressing either UCP3 or UCP4
(see inset, Fig. 4A) and measured the mitochondrial mem-
brane potential. Relative to controls, expression of UCP3 in
293T cells signi¢cantly reduced the £uorescent peak value
ratio (593 nm/532 nm) by 15% (P6 0.01; Fig. 4A), indicative
of a decline in mitochondrial membrane potential. Similar
results were obtained when cells were transfected with the
UCP4-expressing construct, where the ratio dropped by 19%
vs. control (P6 0.01; Fig. 4A,B). The results obtained by
spectro£uorometry were further con¢rmed by £ow cytometry
analysis where the integrated red-to-green intensity ratios fell
by 18% and 24% in UCP3- and UCP4-transfected cells, re-
spectively (P6 0.01 vs. control; n = 3/treatment). Cells treated
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Fig. 2. Tissue distribution of UCP4. Human adult tissue, immune
tissue and cancer cell line Northern (RNA) blots (A); human adult
brain and fetal tissue Northern blots (B) (Clontech) were probed
with UCP4 or UCP2 cDNA according to the manufacturer’s in-
structions. The blots were subsequently probed with a L-actin
cDNA. PBL, peripheral blood leukocytes; Sk. mus., skeletal muscle;
Sm. int., small intestine; HL-60, promyelocytic leukemia; HeLa cell,
HeLa cell line; K-562, chronic myelogenous leukemia; MOLT-4,
lymphoblastic leukemia; Raji, Burkitt’s lymphoma; SW480, colorec-
tal adenocarcinoma; A549, lung carcinoma; G361, melanoma.
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with a chemical uncoupler CCCP showed a dramatic reduc-
tion of the ratio (Fig. 4A,B). No di¡erence in cell viability was
observed among the cells transfected with the vector or UCP-
expressing constructs when the cells were assayed for their
mitochondrial membrane potential (not shown). These ¢nd-
ings suggest that like UCP3, UCP4 is a functional uncoupling
protein.
The brown fat UCP1 is involved in thermogenesis in ro-
dents [3,13] and UCP2 and UCP3 have been implicated in the
regulation of energy expenditure [4,5,8,9,16]. Although its
contribution to the whole body basal metabolic rate is poorly
understood, the brain has long been recognized as one of the
major oxygen-consuming and metabolically active tissues
where mitochondrial proton leak has been observed [11].
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Fig. 3. Subcellular localization of UCP3 and UCP4 in the mitochondria. MCF7 cells were transfected with pcDNA3Flag-UCP3 or pcDNA3-
Flag-UCP4 and stained with anti-Flag and anti-cytochrome c oxidase antibodies as described (see Section 2). A^C: UCP4-transfected cells.
D^F: UCP3-transfected cells. Green images showing mitochondrial staining for cytochrome c oxidase (A, D). Fused yellow images showing
double staining for cytochrome c oxidase and Flag-UCP4 or Flag-UCP3, respectively, indicating their co-localization in the mitochondria
(B, E). Red images showing staining for Flag-UCP4 or Flag-UCP3 (C, F). Anti-Flag: anti-Flag monoclonal antibody; Anti-cyto: anti-
cytochrome c oxidase antibody.
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Thermoregulatory heat production in response to cold has
also been observed in the brain [27]. Since UCP4 transcripts
are exclusively expressed in the brain and it functions as an
uncoupling protein in mammalian cells in vitro, it is conceiv-
able that UCP4 may be responsible for the mitochondrial
proton leak observed in brain tissue, and may potentially be
involved in adaptational thermoregulation and heat produc-
tion in both fetal and adult brains. In addition, since UCPs
function to uncouple the cellular respiratory reaction and re-
active oxygen species (ROS) have been associated with apop-
tosis in neurons [28], it is interesting to speculate that UCP4
may play a regulatory role in the generation of ROS, and that
dysregulation of UCP4 function may be involved in develop-
ment of certain pathological conditions, including neural de-
generative disorders.
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Fig. 4. Ectopic expression of UCP4 in mammalian cells reduces mi-
tochondrial membrane potential. A: 293T cells were transfected
with DNA constructs as indicated and the mitochondrial membrane
potential analyzed as described in Section 2. Expression of UCP3 or
UCP4 in these cells elicits a signi¢cant decline in the 593 nm/532
nm £uorescence peak ratio. The change in ratio, which tracks the
mitochondrial membrane potential, was highly signi¢cant and de-
creased by 15^19% relative to the control (*P6 0.01 vs. control,
Fisher’s protected LSD; n = 9). The NH2-terminal Flag tag had no
e¡ect on the activity of UCP3 or UCP4 (not shown). Flag-tagged
UCP3 and UCP4 expressed in 293T cells were detected by Western
blot analysis using anti-Flag M2 monoclonal antibody (Kodak) and
ECL detection kit (Pierce) (see inset). B: Representative £uorescence
wavelength scans of transfected cells treated with JC-1 are shown.
The drop in £uorescence peak intensity at 593 nm in UCP4-trans-
fected cells relative to the control-transfected cells is indicative of a
decrease in membrane potential. Cells transfected with UCP3 in
parallel yielded a pattern mimicking that of UCP4 (not shown).
Treatment of the control cells with CCCP strongly suppressed the
peak intensity.
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